An interventional study of optical coherence tomography and fractional flow reserve and Coronary angiography in Coronary Artery Disease, Image and Atheroscleroses, Coronary, sponsored by Korea University Guro Hospital. Recruiting at 1 site in South Korea. Open to participants aged 19 Years and older. Per ClinicalTrials.gov, last updated 2026-09-30.
Sponsored by Korea University Guro Hospital · Not applicable, Interventional, and Treatment
The present study is a prospective randomized clinical trial aimed to compare the therapeutic strategy of angiography-guided versus concurrent OCT/FFR-guided intervention in patients with coronary artery disease.
Most previous clinical trials have assessed various interventional strategies guided by intravascular imaging (intravascular imaging-guided PCI), fractional flow reserve (FFR-guided PCI), or conventional angiography (angiography-guided PCI) to compare differences in treatment outcomes. Until now, it remains unclear whether optimizing procedures based on both intravascular imaging and fractional flow reserve indices would lead to improved treatment outcomes compared to PCI guided solely by conventional angiography. Moreover, there are no studies comparing a treatment strategy that combines optical coherence tomography (OCT) and FFR to angiography-guided procedures. Hence, this study aims to compare the clinical effectiveness and therapeutic impact of concurrent guidance using FFR and OCT in patients undergoing coronary artery stent implantation, as compared to procedures guided solely by conventional angiography.
Exclusion Criteria:
This group of patients are intended to undergo PCI with conventional angiography-guidance. Procedural optimization determined by angiographic assessment.
Diagnostic Test: Coronary angiography
This group of patients are intended to undergo PCI with concurrent OCT/FFR-guidance. Procedural optimization determined by OCT and FFR assessment.
Diagnostic Test: optical coherence tomography and fractional flow reserve · Diagnostic Test: Coronary angiography
The assessment of pre-procedural lesions and optimization status of implanted stents will involve both intracoronary imaging and physiological indices.
The assessment of pre-procedural lesions and optimization status of implanted stents will be determined by conventional coronary angiography
Rate of target vessel failure (TVF)
a composite endpoint of cardiac death, target vessel-related non-fatal myocardial infarction, clinically driven-target vessel revascularization
Time frame: 1-year
Rate of all-cause mortality
cardiac and non-cardiac death
Time frame: 1-year
Rate of any myocardial infarction (MI)
myocardial infarction due to target vessel and non-target vessel failure
Time frame: 1-year
Rate of clinically-driven target vessel revascularization (TVR)
clinically-driven target vessel revascularization
Time frame: 1-year
Rate of any revascularization
clinically-driven target lesion and non-target lesion revascularization
Time frame: 1-year
Rate of stent thrombosis (acute, subacute, late, very late)
stent thrombosis based on presenting time after the index procedure
Time frame: 1-year
Rate of BARC-defined bleeding
clinically-relevant bleeding event based on BARC classification
Time frame: 1-year
FFR optimization rate
1\) Post-PCI FFR ≥ 0.90, or 2) Post-PCI FFR (LAD) ≥ 0.82, or 3) Post-PCI FFR (non-LAD) ≥ 0.88, 4) Stent-segment ΔFFR ≤0.05
Time frame: Immediately after index procedure
OCT optimization rate
1\) Post-PCI MSA ≥ 4.5 mm2, and 2) Post-PCI expansion ≥ 80%
Time frame: Immediately after index procedure
Plan to share: Undecided — Individual participant data will be available to qualified researchers only upon reasonable request and appropriate proposal to the principal investigator.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Korea University Guro Hospital